Stephanie Diaz
Manager of Investor Relations
Replay available
Viking Therapeutics, Inc. (LSE: 0VQA) Q2 2025 earnings conference call, held 2025-07-23. Replay captured from the company's public earnings webcast.

Manager of Investor Relations
President and CEO
Chief Financial Officer
Analyst, Raymond James
Analyst, Truist Securities
Analyst, B. Reilly Securities
Analyst, Oppenheimer
Analyst, JP Morgan
Watch the replay and follow the connected company analysis, news, and investor updates for Viking Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.939 Welcome to the Viking Therapeutics Second Quarter 2025 Financial Results Conference Call. 00:00:05.939 -- 00:00:09.683 At this time, all participants are in a listen-only mode. 00:00:09.683 -- 00:00:13.749 Following management's prepared remarks, we will hold a Q&A session. 00:00:13.749 -- 00:00:18.395 To ask a question at that time, please press the star key followed by 1 on your touchtone 00:00:18.395 -- 00:00:23.781 phone. If anyone has difficulty hearing the conference, please press star 0 00:00:23.781 -- 00:00:28.978 for operator assistance. As a reminder, this conference call is being recorded today, 00:00:28.978 -- 00:00:34.346 July 23rd, 2025. I would now like to turn the conference over to Vikings Manager 00:00:34.346 -- 00:00:39.033 of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie. 00:00:39.033 -- 00:00:42.338 Hello, and thank you all for participating in today's call. 00:00:42.338 -- 00:00:48.046 Joining me today is Brian Land, Vikings President and CEO, and Greg Zanty, Vikings 00:00:48.046 -- 00:00:53.054 CFO. Before we begin, I'd like to caution that comments made during this conference call 00:00:53.054 -- 00:00:58.372 today, July 23rd, 2025, will contain forward-looking statements under the safe harbor 00:00:58.372 -- 00:01:03.499 provisions of the U.S. Private Securities Litigation Reform Act of 1995, 00:01:03.499 -- 00:01:07.445 including statements about Vikings' expectations regarding its development activities, 00:01:07.445 -- 00:01:09.628 timelines, and milestones. 00:01:09.628 -- 00:01:13.934 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:01:13.934 -- 00:01:18.861 results to differ materially and adversely, and reported results should not be consid...